About Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc. (ZBH) has been publicly traded since 2001, making it a 25-year-old public company. It operates in the Medical Devices industry within the Healthcare sector. The company is headquartered in Warsaw, United States and employs approximately 17,000 people. With a market capitalization of $18 billion, ZBH is a large established company.
Key Statistics
- Current Price
- $93.20
- Market Cap
- $18.47B
- 52-Week High
- $114.44
- 52-Week Low
- $84.59
- Sector
- Healthcare
- Industry
- Medical Devices
$1,000 Invested
Monthly Returns Heatmap
Annual Returns
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | +3.65% | $89.92 | $93.20 |
| 2025 | -14.03% | $104.60 | $89.92 |
| 2024 | -12.46% | $119.48 | $104.60 |
| 2023 | -3.81% | $124.21 | $119.48 |
| 2022 | +4.23% | $119.17 | $124.21 |
| 2021 | -17.02% | $143.61 | $119.17 |
| 2020 | +3.77% | $138.39 | $143.61 |
| 2019 | +45.37% | $95.20 | $138.39 |
| 2018 | -13.30% | $109.81 | $95.20 |
| 2017 | +17.86% | $93.17 | $109.81 |
| 2016 | +1.46% | $91.83 | $93.17 |
| 2015 | -8.80% | $100.68 | $91.83 |
| 2014 | +22.76% | $82.02 | $100.68 |
| 2013 | +41.20% | $58.09 | $82.02 |
| 2012 | +26.17% | $46.04 | $58.09 |
| 2011 | -0.48% | $46.26 | $46.04 |
| 2010 | -9.19% | $50.94 | $46.26 |
| 2009 | +46.24% | $34.83 | $50.94 |
| 2008 | -38.90% | $57.01 | $34.83 |
| 2007 | -15.60% | $67.55 | $57.01 |
| 2006 | +16.22% | $58.12 | $67.55 |
| 2005 | -15.83% | $69.05 | $58.12 |
| 2004 | +13.81% | $60.67 | $69.05 |
| 2003 | +69.56% | $35.78 | $60.67 |
| 2002 | +35.95% | $26.32 | $35.78 |
Valuation
ZBH currently trades at a trailing P/E ratio of 26.3, which is considered high relative to the broader market. The forward P/E of 10.4 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 1.4. The price-to-sales ratio is 2.2.
Dividends
Zimmer Biomet Holdings, Inc. pays a dividend to shareholders with a current yield of 1.03%. This translates to $0.96 per share annually. The payout ratio of 27% indicates sustainable dividend coverage.
Risk & Volatility
ZBH has a beta of 0.59, indicating it is less volatile than the overall market. The stock's 52-week range is $84.59 to $114.44, and it currently trades in the lower half of its 52-week range.
Analyst Ratings
Based on 23 analyst opinions, ZBH has a consensus "hold" rating. The average price target of $102.65 suggests 10.1% upside from current levels.
Frequently Asked Questions
What does Zimmer Biomet Holdings, Inc. do? ▼
Zimmer Biomet Holdings, Inc. is a Medical Devices company operating in the Healthcare sector. The company is headquartered in Warsaw, United States.
What sector is ZBH in? ▼
ZBH operates in the Healthcare sector, specifically in the Medical Devices industry.
When did ZBH go public? ▼
Zimmer Biomet Holdings, Inc. went public in 2001, making it a 25-year-old public company as of 2026.
How much would $1,000 invested in ZBH 5 years ago be worth today? ▼
A $1,000 investment in ZBH five years ago would be worth approximately $638 today, representing a -36.2% return.
Does ZBH pay dividends? ▼
Yes, Zimmer Biomet Holdings, Inc. pays a dividend with a current yield of 1.03%, which is $0.96 per share annually.
What is ZBH's market cap? ▼
Zimmer Biomet Holdings, Inc. has a market capitalization of $18 billion, classifying it as a large-cap company.
What is ZBH's P/E ratio? ▼
ZBH has a trailing P/E ratio of 26.3 and a forward P/E of 10.4, which measures how much investors are paying per dollar of earnings.
Is ZBH a buy, hold, or sell? ▼
Based on 23 opinions, ZBH has a consensus "hold" rating. The average price target is $102.65.
Last updated: 3/14/2026